Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

Date:

Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

The Genentech logo displayed at the company’s headquarters in San Francisco in a file photo. Justin Sullivan/Getty Images

Roche Group’s Genentech has joined the growing ranks of pharmaceutical companies selling prescription drugs directly to patients by making its Xofluza antiviral flu medicine available through online pharmacies.

Genentech’s Direct-to-Patient (DTP) program allows patients to order the single-dose vaccine from Alto Pharmacy, Amazon Pharmacy, and Mark Cuban’s Cost Plus Drugs, San Francisco-based Genentech said on Oct. 16. Patients can order the vaccine for $50, a 70-percent reduction from its list price, Genentech said.

spot_imgspot_imgspot_img

Share post:

More like this
Related

Trump Says He May Consider Withdrawing Troops From Italy, Spain

U.S. President Donald Trump meets with Italian Prime Minister...

China a Tougher Foe Than the Soviet Union, Diplomats Told at Memorial to Communisms Victims

WASHINGTON—Former U.S. Ambassador for International Religious Freedom Sam Brownback...

Bessent, Rubio Speak With Chinese Officials About TrumpXi Summit

(L-R) U.S. Trade Representative Jamieson Greer, Secretary of Commerce...

Senators Introduce Bipartisan Legislation to Tighten US Ban on Chinese Vehicles

Sen. Bernie Moreno (R-Ohio) speaks during a hearing on...